Literature DB >> 28007051

The effect of standardised cancer pathways on Danish cancer patients' dissatisfaction with waiting time.

Trine Louise Dahl1, Peter Vedsted, Henry Jensen.   

Abstract

INTRODUCTION: Standardised cancer patient pathways (CPPs) were implemented in Denmark in 2008 to reduce the waiting time during the diagnostic process and hereby improve patient satisfaction. The aim of this study was to investigate whether patient-reported dissatisfaction with long waiting times has changed from "before" to "after" the implementation of CPPs.
METHODS: We conducted a comparative cohort study by comparing the patient-reported dissatisfaction with long waiting time before (2004/2005) and after (2010) CPP implementation. Logistic regression was used to estimate the odds ratios (ORs) for patient-reported dissatisfaction after CPP implementation compared with before.
RESULTS: Fewer patients reported dissatisfaction with long waiting time from the time of referral by their general practitioner (GP) to the first consultation at the hospital across the time of CPP implementation (p < 0.001) (adjusted OR = 0.6 (95% confidence interval (CI): 0.5-0.8)). More patients reported dissatisfaction with long waiting time to get an appointment with their GP across the time of CPP implementation (p < 0.001) (adjusted OR = 3.7 (95% CI: 2.5-5.3)).
CONCLUSION: CPP implementation in Denmark was associated with a reduced level of patient-reported dissatisfaction with long waiting time from the time of referral to the first consultation at the hospital. This indicates that the CPP objective of increasing patient satisfaction may have been achieved. Nevertheless, more patients reported dissatisfaction with long waiting time to get an appointment with their GP. FUNDING: none. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Year:  2017        PMID: 28007051

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  10 in total

Review 1.  Symptom Signatures and Diagnostic Timeliness in Cancer Patients: A Review of Current Evidence.

Authors:  Minjoung M Koo; William Hamilton; Fiona M Walter; Greg P Rubin; Georgios Lyratzopoulos
Journal:  Neoplasia       Date:  2017-12-16       Impact factor: 5.715

2.  When time matters: a qualitative study on hospital staff's strategies for meeting the target times in cancer patient pathways.

Authors:  Line Melby; Erna Håland
Journal:  BMC Health Serv Res       Date:  2021-03-09       Impact factor: 2.655

3.  Conceptual Framework to Guide Early Diagnosis Programs for Symptomatic Cancer as Part of Global Cancer Control.

Authors:  Minjoung Monica Koo; Karla Unger-Saldaña; Amos D Mwaka; Marilys Corbex; Ophira Ginsburg; Fiona M Walter; Natalia Calanzani; Jennifer Moodley; Greg P Rubin; Georgios Lyratzopoulos
Journal:  JCO Glob Oncol       Date:  2021-01

4.  Shifting between roles of a customer and a seller - patients' experiences of the encounter with primary care physicians when suspicions of cancer exist.

Authors:  Cecilia Hultstrand; Anna-Britt Coe; Mikael Lilja; Senada Hajdarevic
Journal:  Int J Qual Stud Health Well-being       Date:  2021-12

Review 5.  Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.

Authors:  George N Okoli; Otto L T Lam; Viraj K Reddy; Leslie Copstein; Nicole Askin; Anubha Prashad; Jennifer Stiff; Satya Rashi Khare; Robyn Leonard; Wasifa Zarin; Andrea C Tricco; Ahmed M Abou-Setta
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 2.692

6.  Care needs and preferences from the perspective of COVID-19 patients: A qualitative study.

Authors:  Malihe Sadat Moayed; Esmail Heidaranlu; Akram Parandeh
Journal:  Med J Islam Repub Iran       Date:  2021-05-19

7.  Patient experiences of waiting times in standardised cancer patient pathways in Norway - a qualitative interview study.

Authors:  Marit Solbjør; Kari Sand; Bente Ervik; Line Melby
Journal:  BMC Health Serv Res       Date:  2021-07-05       Impact factor: 2.655

8.  The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study.

Authors:  Vicky L M N Soomers; Ingrid M E Desar; Lonneke V van de Poll-Franse; Michiel A J van de Sande; Jacco J de Haan; Cornelis Verhoef; Ingeborg J H Vriens; Winan J van Houdt; Johannes J Bonenkamp; Winette T A van der Graaf; Olga Husson
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

9.  Effects of oncological care pathways in primary and secondary care on patient, professional and health systems outcomes: a systematic review and meta-analysis.

Authors:  Jolanda C van Hoeve; Robin W M Vernooij; Michelle Fiander; Peter Nieboer; Sabine Siesling; Thomas Rotter
Journal:  Syst Rev       Date:  2020-10-25

10.  Associations between diagnostic pathways and care experience in colorectal cancer: evidence from patient-reported data.

Authors:  Theodosia Salika; Gary A Abel; Silvia C Mendonca; Christian von Wagner; Cristina Renzi; Annie Herbert; Sean McPhail; Georgios Lyratzopoulos
Journal:  Frontline Gastroenterol       Date:  2018-04-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.